Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Raising capital?

<< Previous

Bullboard Posts

Next >>

Comment by guerreiroon Nov 10, 2010 12:20pm

181 Views

Post# 17686974

RE: RE: Raising capital?

Agree; However the way the stock is being held back it appears that whatever deal is taking place is around .50 cents. ie; financing, merger or joint venture. I will just keep buying on pullbacks and wait for the robust day.
Have you noticed that JDM warrants have expired!!!.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale